A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Prof. Bora M Eldem
Advertisement
Articles by Prof. Bora M Eldem
Advertisement
Latest Updated Articles
Assessing the quality of real-world evidence in retinal diseasesPublished: November 11th 2021 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Artificial intelligence at the frontlines of ROP care
2
FLORetina 2025: Port delivery system shows reliable 6-month durability and sustained efficacy in neovascular AMD for up to 7 years
3
FLORetina 2025: Fibrosis, a limiting factor in visual acuity outcomes in neovascular AMD
4
FLORetina 2025: Weight and PMA drive foveal maturation in preterm infants
5
